Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 39,029 | 14,148 | 11,649 | 47,467 | 27,447 |
| Marketable Securities | 119,138 | 59,637 | 30,924 | 29,985 | 0 |
| Receivables | 22,366 | 14,590 | 4,352 | 2,113 | 1,191 |
| Inventories | 29,263 | 15,557 | 12,077 | 1,245 | 1,605 |
| TOTAL | $214,257 | $106,751 | $60,922 | $82,649 | $31,055 |
| Non-Current Assets | |||||
| PPE Net | 60,632 | 48,182 | 39,116 | 25,103 | 23,950 |
| Investments And Advances | 24,431 | 0 | 0 | 0 | 0 |
| Intangibles | 24,164 | 11,485 | 11,505 | 5,259 | 8,912 |
| Other Non-Current Assets | 2,588 | 3,402 | 511 | 479 | 2,645 |
| TOTAL | $111,815 | $63,069 | $51,132 | $30,841 | $35,507 |
| Total Assets | $326,072 | $169,820 | $112,054 | $113,490 | $66,562 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 7,039 | 3,182 |
| Accounts payable and accrued liabilities | 6,758 | 3,069 | 2,569 | 3,440 | 4,315 |
| Accrued Expenses | 28,311 | 17,885 | 9,792 | 7,159 | 4,983 |
| Other current liabilities | 276 | 1,020 | 823 | 1,219 | 1,575 |
| TOTAL | $140,010 | $121,943 | $14,156 | $31,911 | $16,322 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 25,191 | 18,537 | 71,664 |
| Deferred Revenues | 1,426 | 1,008 | 972 | 13,054 | 2,267 |
| Other Non-Current Liabilities | 5,409 | 3,416 | 3,132 | 6,357 | 8,821 |
| TOTAL | $14,917 | $6,628 | $32,043 | $33,310 | $98,623 |
| Total Liabilities | $154,927 | $128,571 | $46,199 | $65,221 | $114,945 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 36,236 | 33,714 | 32,656 | 25,411 | N/A |
| Common Shares | 36 | 34 | 33 | 25 | 1 |
| Retained earnings | -310,145 | -296,429 | -232,520 | -180,239 | -136,911 |
| Other shareholders' equity | -80 | 5 | 25 | 13 | -2 |
| TOTAL | $171,145 | $41,249 | $65,855 | $48,269 | $-48,383 |
| Total Liabilities And Equity | $326,072 | $169,820 | $112,054 | $113,490 | $66,562 |